Wealth host Brad Smith discusses some of Wednesday's trending stocks. Novo Nordisk (NVO) stock is sinking after European drugmaker Roche (ROG.SW) reached a deal with Zealand Pharma (ZEAL.CO) to ...
In an increasingly competitive telehealth weight loss market, thoughtful and transparent branding is critical.
Customers can expect a rate hike up to 14 percent as employee welfare costs surge related to Ozempic and drugs like it.
Swiss drugmaker Roche on Wednesday announced a major deal in the weight-loss category, agreeing to pay up to $5.3 billion to Zealand Pharma in a licensing and development agreement. Zealand Pharma's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results